Veeva Systems (VEEV) AI Stock Analysis

• Market Cap: $31.18B
• Dividend Yield: N/A
• Average Volume (3M): 2.48M
• Price to Earnings (P/E): 36.7
• Beta (1Y): 1.00
• Revenue Growth: 15.96%
• EPS Growth: 27.91%
• Country: US
• Employees: 7,291
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 2.06
• Shares Outstanding: 164,381,850
• 10 Day Avg. Volume: 2,606,320
• 30 Day Avg. Volume: 2,475,404
• PEG Ratio: 1.42
• Price to Book (P/B): 4.63
• Price to Sales (P/S): 10.44
• P/FCF Ratio: 23.58
• Enterprise Value/Market Cap: 0.94
• Enterprise Value/Revenue: 9.21
• Enterprise Value/Gross Profit: 12.19
• Enterprise Value/Ebitda: 30.77
• 1Y Price Target: $266.36
• Price Target Upside: 40.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 24
• EPS Forecast (FY): 8.85
• Revenue Forecast (FY): $3.60B

• Rating: 75 Outperform
• Price Target: $212.00 ▲(11.76% Upside)
• Action: Reiterated Date: 03/05/26
• Date: Action: Reiterated 03/05/26

The score is driven primarily by strong financial quality—high margins, strong free cash flow, and a low-leverage balance sheet—supported by a largely positive earnings outlook (FY2027 growth guidance and solid execution). Offsetting these strengths are weak technicals (price below key moving averages with negative MACD) and a premium valuation (P/E ~36.7) amid recently slowed growth.

Positive Factors

Recurring subscription model & multi-product breadth

Veeva’s core revenue mix is recurring subscription sales across Vault, Commercial Solutions and related services. This durable model supports predictable cashflows, high customer retention and multi-year expansion via cross-sell of adjacent regulated applications, reducing revenue volatility long-term.

High margins and strong free cash flow

Sustained high gross margins and mid-to-high operating margins drive robust free cash flow generation. FCF near $1.4B and cash conversion close to net income provide financial flexibility to fund R&D, services scale, and returns to shareholders while insulating the business from cyclical pressures.

Conservative balance sheet and $2B buyback

Extremely low leverage preserves flexibility for multi-year investments and M&A; the $2B repurchase program signals management confidence and offers a disciplined capital-return lever. Together these strengthen long-term shareholder optionality without compromising operating investments.

Negative Factors

Revenue growth deceleration

A sustained slowdown in top-line expansion materially limits the pace at which scale economics and margin expansion can translate into higher absolute earnings. Slower growth raises dependency on cross-sell, new product ramps and services expansion to sustain long-term upside versus past cadence.

Long sales cycles and migration execution risk

Enterprise migrations (EDC, RTSM, safety databases) require lengthy evaluation and conservative customers, creating lumpy revenue and multi-quarter timing risk. Execution missteps or slower-than-expected adoption can delay revenue recognition and dampen multi-year growth trajectories.

Product concentration / comparability & early AI economics

Heavy near-term reliance on strong Crossix performance increases sensitivity to comparability cycles, while AI initiatives remain early-stage and not a meaningful 2027 revenue driver. This combination raises uncertainty on where next material upside will sustainably come from.

Veeva Systems Business Overview & Revenue Model

Company Description

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

How the Company Makes Money

Veeva Systems generates revenue primarily through a subscription-based model, where clients pay for access to its cloud-based software solutions. The company offers various pricing tiers based on the specific services and features utilized by its customers. Key revenue streams include subscriptions for its core products like Veeva Vault and Veeva CRM, as well as additional services such as consulting and support. Veeva also derives income from multi-year contracts with clients, which provide predictable long-term revenue. Significant partnerships with major pharmaceutical companies and strategic alliances in the life sciences ecosystem further enhance its market position and contribute to sustained earnings growth, as these collaborations often lead to increased adoption of Veeva's platform and services.

Veeva Systems Financial Statement Overview

Summary

High-quality fundamentals: strong and resilient profitability (gross margin low-to-mid 70s; net margin improving to ~28%), excellent cash generation (FCF reaching ~1.4B in 2026 with solid conversion), and a very conservative balance sheet with minimal leverage. The main constraint is the meaningful slowdown in recent revenue growth, which caps the score.

Income Statement

Veeva shows consistently strong profitability with gross margin holding in the low-to-mid 70% range and net margin improving to ~28% in 2026. Revenue has grown steadily over the period, but growth has decelerated meaningfully in recent years (from ~33% in 2021 to low-single digits in 2026), which is the primary watch item. Overall, the business remains high-quality and margin-resilient, but the slowing top-line trajectory caps the score.

Balance Sheet

The balance sheet is very conservative: debt is minimal versus equity (debt-to-equity roughly ~0.01–0.03 across the years), and equity has compounded strongly alongside asset growth. Returns on equity remain solid (generally low-to-mid teens), though they’ve come down from earlier highs as the company has scaled. Strength is clearly financial flexibility and low leverage; the main trade-off is that ROE is good rather than exceptional.

Cash Flow

Cash generation is a standout: operating cash flow and free cash flow have grown strongly over time, reaching ~$1.4B in 2026, with free cash flow closely tracking net income (near 1.0x in most years). That said, cash conversion versus earnings (operating cash flow relative to net income) is solid but not consistently above 1.0, and recent free-cash-flow growth is modest in some years, mirroring the broader growth slowdown. Overall cash flow quality remains very strong.

Breakdown	Jan 2026	Jan 2025	Jan 2024	Jan 2023	Jan 2022
Income Statement
Total Revenue	3.20B	2.75B	2.36B	2.16B	1.85B
Gross Profit	2.41B	2.05B	1.69B	1.55B	1.35B
EBITDA	916.37M	730.82M	461.96M	488.21M	532.94M
Net Income	908.91M	714.14M	525.71M	487.71M	427.39M
Balance Sheet
Total Assets	8.98B	7.34B	5.91B	4.80B	3.82B
Cash, Cash Equivalents and Short-Term Investments	6.56B	5.15B	4.03B	3.10B	2.38B
Total Debt	95.86M	75.78M	55.77M	60.98M	54.59M
Total Liabilities	1.76B	1.51B	1.27B	1.09B	904.83M
Stockholders Equity	7.21B	5.83B	4.64B	3.72B	2.91B
Cash Flow
Free Cash Flow	1.42B	1.07B	885.14M	766.96M	750.25M
Operating Cash Flow	1.42B	1.09B	911.34M	780.47M	764.46M
Investing Cash Flow	-1.10B	-700.14M	-1.08B	-1.01B	-346.15M
Financing Cash Flow	-9.33M	26.11M	-16.19M	-19.38M	-4.14M

Veeva Systems Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 189.69
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For VEEV, the sentiment is Neutral. The current price of 189.69 is above the 20-day moving average (MA) of 182.65, below the 50-day MA of 203.32, and below the 200-day MA of 257.14, indicating a neutral trend. The MACD of -2.41 indicates Negative momentum. The RSI at 48.51 is Neutral, neither overbought nor oversold. The STOCH value of 62.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for VEEV.

Veeva Systems Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VEEV	75 Outperform	$31.18B	36.72	13.41%	―	15.96%	27.91%
HQY	74 Outperform	$6.71B	39.34	9.01%	―	12.20%	98.75%
DOCS	71 Outperform	$4.58B	33.71	22.89%	―	20.21%	44.14%
BTSG	69 Neutral	$8.00B	39.79	10.71%	―	17.23%	―
GEHC	64 Neutral	$33.15B	50.87	17.11%	0.17%	3.52%	32.21%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TEM	49 Neutral	$9.06B	-42.00	-59.95%	―	72.58%	76.81%

Veeva Systems Corporate Events

Veeva Systems Announces First-Ever $2 Billion Share Buyback

On January 5, 2026, Veeva Systems announced that its board had authorized the company’s first-ever share repurchase program, allowing the buyback of up to $2 billion of its Class A common stock over a two-year period. Management framed the move as a way to return capital to shareholders while underscoring confidence in Veeva’s long-term growth trajectory, supported by its diversified multi-product business and strong cash generation, with repurchases to be executed at management’s discretion depending on market conditions and other factors, and the program able to be modified, suspended, or canceled at any time.

The most recent analyst rating on (VEEV) stock is a Buy with a $320.00 price target. To see the full list of analyst forecasts on Veeva Systems stock, see the VEEV Stock Forecast page.

Veeva Systems Appoints New Principal Accounting Officer

On December 10, 2025, Veeva Systems Inc. announced the appointment of Vipin Kondath as the principal accounting officer, effective December 12, 2025. Kondath, who has been with Veeva since 2019, previously served as VP, Corporate Controller, and Senior Director of Revenue Accounting. His appointment does not alter his compensation or involve any family or material interest ties with Veeva’s directors or executives.

The most recent analyst rating on (VEEV) stock is a Buy with a $222.00 price target. To see the full list of analyst forecasts on Veeva Systems stock, see the VEEV Stock Forecast page.